Response to Solicitation of Comments on Professional Organizations and State Governments Requirements for Poison Control Center Certification, 70519-70520 [E6-20564]

Download as PDF 70519 Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices Number of respondents Form Responses per respondent Total responses Hours per response Total burden hours NAT ...................................................................................... 100 1 100 1 100 Total .............................................................................. 600 ........................ 600 ........................ 600 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to: John Kraemer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503. Dated: November 22, 2006. Caroline Lewis, Acting, Associate Administrator for Administration and Financial Management. [FR Doc. E6–20531 Filed 12–4–06; 8:45 am] BILLING CODE 4165–15–P basis for NACNEP’s mandated Seventh Annual Report. For Further Information Contact: Anyone interested in obtaining a roster of members, minutes of the meeting, or other relevant information should write or contact Dr. Joan Weiss, Executive Secretary, National Advisory Council on Nurse Education and Practice, Parklawn Building, Room 9–35, 5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 443–5688. Dated: November 29, 2006. Caroline Lewis, Acting Associate Administrator for Administration and Financial Management. [FR Doc. E6–20532 Filed 12–4–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Health Resources and Services Administration National Advisory Council on Nurse Education and Practice; Notice of Meeting ycherry on PROD1PC64 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: National Advisory Council on Nurse Education and Practice (NACNEP). Dates and Times: December 11, 2006, 9 a.m.–5 p.m. December 12, 2006, 7:30 a.m.–3 p.m. Place: The Madison Hotel, 1177 15th Street, NW., Washington, DC 20005. Status: The meeting will be open to the public. Agenda: Agency and Bureau administrative updates will be provided. The purpose of the meeting will be to discuss the role of nursing in developing surge capacity, with a series of panel discussions relating to the nursing workforce, integration of health information technology, providing care to special populations, and integrating surge capacity into the nursing curriculum. Representatives from the Department of Health and Human Services, Department of Homeland Security, Centers for Disease Control and Prevention, Department of Veteran’s Affairs, American Hospital Association, INOVA Health Systems, and American Red Cross will be presenting. During this meeting, Council workgroups will deliberate on content presented and formulate recommendations to the Secretary of Health and Human Services and the Congress on role of nursing in developing surge capacity. This meeting will form the VerDate Aug<31>2005 15:14 Dec 04, 2006 Jkt 211001 Response to Solicitation of Comments on Professional Organizations and State Governments Requirements for Poison Control Center Certification A notice was published in the Federal Register by the Health Resources and Services Administration (HRSA) on April 8, 2005 (Volume 70, No. 67 pp. 18036–18037), soliciting public comment regarding the guidelines by which the Secretary shall approve professional organizations and State governments as having in effect standards for Poison Control Center (PCC) certification. Respondents were asked to submit recommended guidelines for approving professional organizations and State governments’ standards per Public Law 108–194 section 1273 (c). Written comments were to be post marked no later than June 5, 2005 for consideration. The HRSA was seeking comment on the following issues: 1. Modeling the guidelines after certification requirements that are currently being used to certify PCCs; 2. Elements of approval that the guidelines should include and justification of the elements; 3. Guidelines applying to all State governments; 4. Guidelines applying to all professional organizations; and 5. Inclusion or re-certification as an element of certification. PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 Fifty-two (52) comments were received. Fifty-one (51) comments were submitted by poison control centers (PCCs), 15 of which came from the same center. All of the poison centers are members of the American Association of Poison Control Centers (AAPCC) and certified by this association. One (1) comment was also submitted from a professional organization whose membership includes staff from poison control centers. Following is a summary of the comments received and the HRSA’s recommendations. While the HRSA did not receive any specific comments on the issues requested in the Federal Register Notice sited above, 50 comments indicated a strong advisement for the HRSA to continue to accept the present certification process instituted by the AAPCC as the single certifying body for poison control centers. These respondents concurred that the current certification structure is ‘‘fair, costefficient and already subscribed to by nearly all of poison centers in the United States.’’ Additional responses concluded that resources used to develop, implement and maintain a new certification process would be duplicative and costly. Comments also suggested that the current certification process is used as a mechanism to maintain quality poison prevention education and treatment services. The legislation does not call for the HRSA to change the certification process, but does require the Secretary to approve standards for certification. Therefore, the HRSA was seeking public comment on what guidelines the HRSA should use for approving professional organizations and State governments’ standards for certification. Of these 50 comments, an additional response indicated that if a State certification system were to be developed it should meet or exceed the certification criteria established by the AAPCC. There was one commenter in support of a State certification process. This commenter indicated that many States currently determine the healthcare standards of their residents and have the ability to employ certification standards for PCCs. In this response, it was also communicated that a State certification process should be developed and modeled after the E:\FR\FM\05DEN1.SGM 05DEN1 70520 Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices current certification process with the exception of the requirement ‘‘for nurse/ pharmacist certification through AAPCC.’’ From the comments received, there is consensus support for the AAPCC certification program. The guidelines by which the Secretary shall approve a professional organization and/or State government as having standards for certification will be that any certification program must meet or exceed current certification standards being used by AAPCC to certify PCCs. Send comments to Maxine Jones, HRSA, HSB, Division of Healthcare Preparedness, Healthcare Systems Bureau, Room 13–103, 5600 Fishers Lane, Rockville, MD 20857. Comments should be received within 60 days of this notice. Dated: November 28, 2006. Elizabeth M. Duke, Administrator. [FR Doc. E6–20564 Filed 12–4–06; 8:45 am] BILLING CODE 4165–15–P National Institutes of Health Second Annual Philip S. Chen, Jr. Distinguished Lecture on Innovation and Technology Transfer National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The Office of the Director, NIH, invites you to the second annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. DATES: Friday, January 26, 2007, at 1 p.m. NIH campus, 9000 Rockville Pike, Bethesda MD, NIH Clinical Center (Building 10), Lipsett Auditorium. ADDRESSES: For additional information, sign language interpretation or accommodation for disabilities, please contact Colleen Crone at 301–496–1921 or cronec@od.nih.gov. FOR FURTHER INFORMATION CONTACT: Dr. Douglas R. Lowy will present ‘‘The Science, Technology and Promise of Preventive HPV Vaccines.’’ Dr. Lowy is Chief of the Basic Research Laboratory and the Laboratory of Cellular Oncology at the NCI Center for Cancer Research, where he also serves as deputy director. With colleagues at NIH, he developed ycherry on PROD1PC64 with NOTICES VerDate Aug<31>2005 15:14 Dec 04, 2006 Jkt 211001 Dated: November 27, 2006. Bonny Harbinger, Deputy Director, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–20577 Filed 12–4–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES SUPPLEMENTARY INFORMATION: the original technology on which the Merck HPV vaccine, Gardasil, is based. This annual series honors Dr. Philip S. Chen, Jr. for his almost 50 years of service to the National Institutes of Health. Dr. Chen established NIH’s Office of Technology Transfer in 1986 to implement the Federal Technology Transfer Act. The inventions in the Office of Technology Transfer’s intellectual property portfolio are crucial in advancing the NIH mission— making important discoveries that improve health and save lives. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Research in Severe Asthma. Date: December 12, 2006. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Valerie L. Prenger, PhD, Health Scientist Administrator, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, MSC 7924, Room 7214, Bethesda, MD 20892–7924, (301) 435–0270. prengerv@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: November 28, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9525 Filed 12–4–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Development of State-of-the-Art Mechanisms for Epidemiological Research. Date: December 6, 2006. Time: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Eric Zatman, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892– 8401, (301) 435–1438. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Develop a Real-Time fMRI Feedback System that Allows Drug Abusers to Control Cravings and Urges and/or Increase Their Self-Control of Their Drug Taking. Date: December 20, 2006. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). E:\FR\FM\05DEN1.SGM 05DEN1

Agencies

[Federal Register Volume 71, Number 233 (Tuesday, December 5, 2006)]
[Notices]
[Pages 70519-70520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Response to Solicitation of Comments on Professional 
Organizations and State Governments Requirements for Poison Control 
Center Certification

    A notice was published in the Federal Register by the Health 
Resources and Services Administration (HRSA) on April 8, 2005 (Volume 
70, No. 67 pp. 18036-18037), soliciting public comment regarding the 
guidelines by which the Secretary shall approve professional 
organizations and State governments as having in effect standards for 
Poison Control Center (PCC) certification. Respondents were asked to 
submit recommended guidelines for approving professional organizations 
and State governments' standards per Public Law 108-194 section 1273 
(c). Written comments were to be post marked no later than June 5, 2005 
for consideration.
    The HRSA was seeking comment on the following issues:
    1. Modeling the guidelines after certification requirements that 
are currently being used to certify PCCs;
    2. Elements of approval that the guidelines should include and 
justification of the elements;
    3. Guidelines applying to all State governments;
    4. Guidelines applying to all professional organizations; and
    5. Inclusion or re-certification as an element of certification.
    Fifty-two (52) comments were received. Fifty-one (51) comments were 
submitted by poison control centers (PCCs), 15 of which came from the 
same center. All of the poison centers are members of the American 
Association of Poison Control Centers (AAPCC) and certified by this 
association. One (1) comment was also submitted from a professional 
organization whose membership includes staff from poison control 
centers. Following is a summary of the comments received and the HRSA's 
recommendations.
    While the HRSA did not receive any specific comments on the issues 
requested in the Federal Register Notice sited above, 50 comments 
indicated a strong advisement for the HRSA to continue to accept the 
present certification process instituted by the AAPCC as the single 
certifying body for poison control centers. These respondents concurred 
that the current certification structure is ``fair, cost-efficient and 
already subscribed to by nearly all of poison centers in the United 
States.'' Additional responses concluded that resources used to 
develop, implement and maintain a new certification process would be 
duplicative and costly. Comments also suggested that the current 
certification process is used as a mechanism to maintain quality poison 
prevention education and treatment services.
    The legislation does not call for the HRSA to change the 
certification process, but does require the Secretary to approve 
standards for certification. Therefore, the HRSA was seeking public 
comment on what guidelines the HRSA should use for approving 
professional organizations and State governments' standards for 
certification.
    Of these 50 comments, an additional response indicated that if a 
State certification system were to be developed it should meet or 
exceed the certification criteria established by the AAPCC. There was 
one commenter in support of a State certification process. This 
commenter indicated that many States currently determine the healthcare 
standards of their residents and have the ability to employ 
certification standards for PCCs. In this response, it was also 
communicated that a State certification process should be developed and 
modeled after the

[[Page 70520]]

current certification process with the exception of the requirement 
``for nurse/pharmacist certification through AAPCC.''
    From the comments received, there is consensus support for the 
AAPCC certification program. The guidelines by which the Secretary 
shall approve a professional organization and/or State government as 
having standards for certification will be that any certification 
program must meet or exceed current certification standards being used 
by AAPCC to certify PCCs.
    Send comments to Maxine Jones, HRSA, HSB, Division of Healthcare 
Preparedness, Healthcare Systems Bureau, Room 13-103, 5600 Fishers 
Lane, Rockville, MD 20857. Comments should be received within 60 days 
of this notice.

    Dated: November 28, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6-20564 Filed 12-4-06; 8:45 am]
BILLING CODE 4165-15-P